7.87
price up icon3.83%   0.29
after-market Handel nachbörslich: 7.87
loading

Arvinas Inc Aktie (ARVN) Neueste Nachrichten

pulisher
12:57 PM

Is Arvinas Inc. a good long term investmentUnstoppable investment returns - Autocar Professional

12:57 PM
pulisher
09:38 AM

Arvinas Inc. Stock Analysis and ForecastPhenomenal trading returns - Autocar Professional

09:38 AM
pulisher
Jul 22, 2025

What drives Arvinas Inc. stock priceExplosive returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Arvinas Inc. stockFastest-growing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Arvinas (ARVN) Expected to Announce Earnings on Tuesday - MarketBeat

Jul 22, 2025
pulisher
Jul 20, 2025

Arvinas Presents Promising Preclinical Data for BCL6 Degrader ARV-393 in Lymphoma Treatment - MSN

Jul 20, 2025
pulisher
Jul 18, 2025

Arvinas, Inc. (NASDAQ:ARVN) Receives $20.29 Consensus Price Target from Analysts - MarketBeat

Jul 18, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 14, 2025

(ARVN) Proactive Strategies - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 13, 2025

Arvinas (NASDAQ:ARVN) Trading Down 4.6%Here's Why - MarketBeat

Jul 13, 2025
pulisher
Jul 13, 2025

Arvinas: A Potential 'Sum Of The Parts' Story (NASDAQ:ARVN) - Seeking Alpha

Jul 13, 2025
pulisher
Jul 10, 2025

Arvinas CEO John Houston to retire - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Arvinas stock slides after eliminating trials, reducing workforce - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Arvinas CEO John Houston to retire, remain as board chair By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Becton Dickinson, Spotify, Arvinas, Twilio, Lumen: Trending by Analysts - MSN

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas (ARVN) Soars 2.62% on CEO Transition - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas CEO John Houston to retire, remain as board chair - Investing.com Australia

Jul 09, 2025
pulisher
Jul 09, 2025

Gilead signs lenacapavir access deal; Arvinas CEO to step down - BioPharma Dive

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas Announces Retirement of CEO John Houston, Ph.D., - citybiz

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas CEO John Houston to retire after successor is named, will remain board chair - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas CEO John Houston to retire after successor is named, will remain board chair By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas' CEO to Retire; Search for Successor Begins - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Arvinas Announces Retirement of Chief Executive Officer and Succession Plan - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

Pioneering Biotech CEO Steps Down: How Arvinas' Houston Transformed Protein Degradation Drug Development - Stock Titan

Jul 09, 2025
pulisher
Jun 30, 2025

Arvinas announces board resignation and reports annual meeting voting results By Investing.com - Investing.com South Africa

Jun 30, 2025
pulisher
Jun 30, 2025

Arvinas, Inc. Announces John Young Decides to Resign from its Board of Directors and Compensation Committee, Effective June 30, 2025 - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Arvinas announces board resignation and reports annual meeting voting results - Investing.com

Jun 30, 2025
pulisher
Jun 28, 2025

Arvinas, Inc. (NASDAQ:ARVN) CFO Andrew Saik Sells 5,700 Shares - MarketBeat

Jun 28, 2025
pulisher
Jun 23, 2025

Bragar Eagel & Squire, P.C. Is Investigating Arvinas, Semler, and Abacus and Encourages Investors to Contact the Firm - TradingView

Jun 23, 2025
pulisher
Jun 20, 2025

Arvinas (NASDAQ:ARVN) Shares Gap UpStill a Buy? - MarketBeat

Jun 20, 2025
pulisher
Jun 18, 2025

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga

Jun 18, 2025
pulisher
Jun 17, 2025

Logos Global Management LP Acquires 4,800,000 Shares in Arvinas Inc - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Logos Global Management LP Issues a Letter to the Board of Arvinas, Inc. - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Wall Street Analysts Believe Arvinas (ARVN) Could Rally 89.85%: Here's is How to Trade - MSN

Jun 17, 2025
pulisher
Jun 14, 2025

Arvinas’s SWOT analysis: vepdegestrant efficacy fuels stock potential amid market challenges - Investing.com

Jun 14, 2025
pulisher
Jun 14, 2025

Analysts Set Expectations for Arvinas FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

ARVN: Arvinas' ARV-393 Shows Promise in Preclinical Lymphoma Stu - GuruFocus

Jun 13, 2025
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):